A study of frenolicin B targets peroxiredoxin 1 and glutaredoxin 3 to trigger ROS/4E-BP1-mediated antitumor effects. Ye et al

Published: 2 November 2018| Version 1 | DOI: 10.17632/wp5jpsrkrn.1
Contributor:
Qing-Bai She

Description

Chemical structures and NMR spectroscopies of compounds 1-12 and 14, probes 1 and 2, and FN-NAC

Files